Crossmark

Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months

Published Online: 2016-09-12

Published Print: 2016-12

Authors

Vold, Steven D.

Voskanyan, Lilit

Tetz, Manfred

Auffarth, Gerd

Masood, Imran

Au, Leon

Ahmed, Iqbal Ike K.

Saheb, Hady
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01443988 at ClinicalTrials.gov

Documents that mention this clinical trial

Newly Diagnosed Primary Open-Angle Glaucoma Randomized to 2 Trabecular Bypass Stents or Prostaglandin: Outcomes Through 36 Months
https://doi.org/10.1007/s40123-016-0065-3
Funding

Funding for this research was provided by:

Glaukos Corporation
License Information

Text and Data Mining valid from 2016-09-12

Version of Record valid from 2016-09-12
More Information

Article History

Received: 29 July 2016

First Online: 12 September 2016

Updates are available Correction dated 2016-11-04